JPML Consolidates Birth Defect Suits Over GSK's Zofran
The U.S. Judicial Panel on Multidistrict Litigation on Tuesday consolidated in Massachusetts district court a number of lawsuits alleging GlaxoSmithKline's "off label" promotion of its anti-nausea drug Zofran for morning sickness...To view the full article, register now.
Already a subscriber? Click here to view full article